Aardvark Therapeutics (AARD) Interest Income - Net (2024 - 2026)

Aardvark Therapeutics has reported Interest Income - Net for 3 years, with the latest figure at $889000.0 in Q1 2026.

• Quarterly Interest Income - Net fell 24.28% year-over-year to $889000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (up 1460.32% YoY) and the FY2025 annual result came in at -$7.2 million, up 54.93% from the prior year.
• Interest Income - Net slipped to $889000.0 in Q1 2026 per AARD's latest filing, from $1.1 million in the prior quarter.
• Over five years, Interest Income - Net peaked at $1.5 million in Q2 2025 and troughed at -$2.5 million in Q4 2024.
• A 3-year average of $583333.3 and a median of $1.0 million in 2024 frame the typical range for Interest Income - Net.
• The sharpest annual moves came in 2025 and 2026: Interest Income - Net jumped 1039.81% in 2025, then fell 24.28% in 2026.
• Over 3 years, Interest Income - Net stood at -$2.5 million in 2024, then jumped by 145.77% to $1.1 million in 2025, then slipped by 20.98% to $889000.0 in 2026.
• According to Business Quant data, Interest Income - Net over the past three periods registered $889000.0, $1.1 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.